6 assets in Lambert-Eaton Myasthenic Syndrome

Therapeutic assets addressing Lambert-Eaton Myasthenic Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Camustine Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Cytarabine Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Etoposide Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Melphalan Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)
Prednisone Lambert-Eaton Myasthenic Syndrome	Fred Hutchinson Cancer Center	P2	CCC (53)